|
2024-06-25 |
2024-06-24 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
1,908
-1.0%
0.66
USD 1,260
|
1,908
-1.0%
|
0.66
|
USD 1,260
|
|
|
2024-06-24 |
2024-06-21 |
B
Purchase
|
Hasnain Faheem
President & CEO
Executive Director
|
372,000
+7.4%
0.67
USD 250,282
|
372,000
+7.4%
|
0.67
|
USD 250,282
|
|
|
2024-06-20 |
2024-06-18 |
B
Purchase
|
Giraudo Bryan
COO/CFO
Officer
|
100,000
+26.3%
0.59
USD 59,110
|
100,000
+26.3%
|
0.59
|
USD 59,110
|
|
|
2024-06-20 |
2024-06-17 |
B
Purchase
|
Smith Robert Paul JR
Chief Commercial Officer
Officer
|
25,000
+inf%
0.60
USD 15,050
|
25,000
+inf%
|
0.60
|
USD 15,050
|
|
|
2024-03-28 |
2024-03-27 |
S
Sale
|
Hasnain Faheem
President & CEO
Executive Director
|
23,172
-16.2%
1.16
USD 26,773
|
23,172
-16.2%
|
1.16
|
USD 26,773
|
|
|
2024-03-28 |
2024-03-27 |
S
Sale
|
Christian Waage
EVP, Tech Ops and Admin
Officer
|
6,430
-1.1%
1.16
USD 7,430
|
6,430
-1.1%
|
1.16
|
USD 7,430
|
|
|
2024-03-28 |
2024-03-27 |
S
Sale
|
Giraudo Bryan
COO/CFO
Officer
|
6,430
-6.5%
1.16
USD 7,431
|
6,430
-6.5%
|
1.16
|
USD 7,431
|
|
|
2024-03-19 |
2024-03-18 |
S
Sale
|
Peterson Caryn
EVP, Regulatory Affairs
Officer
|
4,018
-7.5%
1.33
USD 5,343
|
4,018
-7.5%
|
1.33
|
USD 5,343
|
|
|
2024-03-19 |
2024-03-18 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
4,018
-2.0%
1.33
USD 5,342
|
4,018
-2.0%
|
1.33
|
USD 5,342
|
|
|
2023-11-17 |
2023-11-15 |
B
Purchase
|
Milligan Sandra
Non-Executive Director
|
32,000
+inf%
0.79
USD 25,213
|
32,000
+inf%
|
0.79
|
USD 25,213
|
|
|
2023-11-14 |
2023-11-13 |
B
Purchase
|
Giraudo Bryan
COO/CFO
Officer
|
200,000
+111.1%
0.56
USD 112,880
|
200,000
+111.1%
|
0.56
|
USD 112,880
|
|
|
2023-06-26 |
2023-06-22 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
1,814
-0.9%
1.29
USD 2,340
|
1,814
-0.9%
|
1.29
|
USD 2,340
|
|
|
2023-04-05 |
2023-04-04 |
B
Purchase
|
Giraudo Bryan
COO/CFO
Officer
|
55,000
+77.5%
1.02
USD 56,095
|
55,000
+77.5%
|
1.02
|
USD 56,095
|
|
|
2023-03-22 |
2023-03-22 |
B
Purchase
|
Hasnain Faheem
President & CEO
Executive Director
|
440,500
+10.9%
1.14
USD 503,580
|
440,500
+10.9%
|
1.14
|
USD 503,580
|
|
|
2023-03-22 |
2023-03-21 |
B
Purchase
|
Hasnain Faheem
President & CEO
Executive Director
|
269,389
+7.1%
1.20
USD 322,324
|
269,389
+7.1%
|
1.20
|
USD 322,324
|
|
|
2023-03-22 |
2023-03-20 |
B
Purchase
|
Giraudo Bryan
COO/CFO
Officer
|
50,000
+238.2%
0.97
USD 48,435
|
50,000
+238.2%
|
0.97
|
USD 48,435
|
|
|
2023-03-22 |
2023-03-20 |
B
Purchase
|
Hasnain Faheem
President & CEO
Executive Director
|
168,683
+4.7%
1.03
USD 174,486
|
168,683
+4.7%
|
1.03
|
USD 174,486
|
|
|
2023-03-22 |
2023-03-20 |
B
Purchase
|
Christian Waage
EVP, Tech Ops and Admin
Officer
|
18,500
+133.2%
1.20
USD 22,145
|
18,500
+133.2%
|
1.20
|
USD 22,145
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
6,029
-7.3%
1.10
USD 6,620
|
6,029
-7.3%
|
1.10
|
USD 6,620
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Peterson Caryn
EVP, Regulatory Affairs
Officer
|
7,564
-12.3%
1.10
USD 8,305
|
7,564
-12.3%
|
1.10
|
USD 8,305
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
7,563
-3.7%
1.10
USD 8,304
|
7,563
-3.7%
|
1.10
|
USD 8,304
|
|
|
2022-10-25 |
2022-10-24 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
4,876
-5.6%
12.07
USD 58,868
|
4,876
-5.6%
|
12.07
|
USD 58,868
|
|
|
2022-10-25 |
2022-10-24 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
4,757
-2.3%
12.07
USD 57,431
|
4,757
-2.3%
|
12.07
|
USD 57,431
|
|
|
2022-10-25 |
2022-10-24 |
S
Sale
|
Peterson Caryn
EVP, Regulatory Affairs
Officer
|
4,757
-7.2%
12.07
USD 57,431
|
4,757
-7.2%
|
12.07
|
USD 57,431
|
|
|
2022-07-15 |
2022-07-15 |
B
Purchase
|
Giraudo Bryan
COO/CFO
Officer
|
13,869
+194.8%
7.21
USD 99,995
|
13,869
+194.8%
|
7.21
|
USD 99,995
|
|
|
2022-07-15 |
2022-07-15 |
B
Purchase
|
Christian Waage
EVP, Tech Ops and Admin
Officer
|
6,934
+99.7%
7.21
USD 49,994
|
6,934
+99.7%
|
7.21
|
USD 49,994
|
|
|
2022-07-15 |
2022-07-15 |
B
Purchase
|
Hasnain Faheem
President & CEO
Executive Director
|
138,696
+4.0%
7.21
USD 999,998
|
138,696
+4.0%
|
7.21
|
USD 999,998
|
|
|
2022-07-15 |
2022-07-15 |
B
Purchase
|
Carter Laura
Chief Scientific Officer
Officer
|
6,934
+8.6%
7.21
USD 49,994
|
6,934
+8.6%
|
7.21
|
USD 49,994
|
|
|
2022-07-05 |
2022-07-01 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
8,808
-9.9%
8.25
USD 72,648
|
8,808
-9.9%
|
8.25
|
USD 72,648
|
|
|
2022-06-23 |
2022-06-22 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
1,778
-0.8%
6.88
USD 12,233
|
1,778
-0.8%
|
6.88
|
USD 12,233
|
|
|
2022-05-05 |
2022-05-04 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
1,262
-1.4%
7.20
USD 9,086
|
1,262
-1.4%
|
7.20
|
USD 9,086
|
|
|
2022-03-24 |
2022-03-23 |
S
Sale
|
Hasnain Faheem
President & CEO
Executive Director
|
19,035
-11.7%
8.92
USD 169,697
|
19,035
-11.7%
|
8.92
|
USD 169,697
|
|
|
2022-03-24 |
2022-03-23 |
S
Sale
|
Giraudo Bryan
COO/CFO
Officer
|
10,722
-9.8%
8.92
USD 95,587
|
10,722
-9.8%
|
8.92
|
USD 95,587
|
|
|
2022-03-24 |
2022-03-23 |
S
Sale
|
Christian Waage
EVP, Tech Ops and Admin
Officer
|
10,722
-1.8%
8.92
USD 95,587
|
10,722
-1.8%
|
8.92
|
USD 95,587
|
|
|
2022-03-17 |
2022-03-16 |
S
Sale
|
Peterson Caryn
EVP, Regulatory Affairs
Officer
|
6,279
-8.7%
8.28
USD 51,978
|
6,279
-8.7%
|
8.28
|
USD 51,978
|
|
|
2022-03-17 |
2022-03-16 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
5,002
-5.2%
8.28
USD 41,407
|
5,002
-5.2%
|
8.28
|
USD 41,407
|
|
|
2022-03-17 |
2022-03-16 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
6,278
-2.9%
8.28
USD 51,976
|
6,278
-2.9%
|
8.28
|
USD 51,976
|
|
|
2021-10-26 |
2021-10-25 |
S
Sale
|
Aranda Richard
Chief Medical Officer
Officer
|
2,377
-1.1%
12.25
USD 29,118
|
2,377
-1.1%
|
12.25
|
USD 29,118
|
|
|
2021-10-26 |
2021-10-25 |
S
Sale
|
Peterson Caryn
EVP, Regulatory Affairs
Officer
|
2,377
-3.2%
12.25
USD 29,118
|
2,377
-3.2%
|
12.25
|
USD 29,118
|
|
|
2021-10-26 |
2021-10-25 |
S
Sale
|
Carter Laura
Chief Scientific Officer
Officer
|
2,377
-2.4%
12.25
USD 29,118
|
2,377
-2.4%
|
12.25
|
USD 29,118
|
|
|
2021-03-25 |
2021-03-23 |
S
Sale
|
Salter-Cid Luisa
Chief Scientific Officer
Officer
|
5,491
-2.6%
9.48
USD 52,052
|
5,491
-2.6%
|
9.48
|
USD 52,052
|
|
|
2021-03-25 |
2021-03-23 |
S
Sale
|
Giraudo Bryan
Chief Financial Officer
Officer
|
5,490
-4.8%
9.48
USD 52,046
|
5,490
-4.8%
|
9.48
|
USD 52,046
|
|
|
2021-03-25 |
2021-03-23 |
S
Sale
|
Christian Waage
EVP & General Counsel
Officer
|
5,490
-0.9%
9.48
USD 52,051
|
5,490
-0.9%
|
9.48
|
USD 52,051
|
|
|
2020-10-14 |
2020-10-14 |
B
Purchase
|
Giraudo Bryan
Chief Financial Officer
Officer
|
3,000
+72.8%
10.01
USD 30,036
|
3,000
+72.8%
|
10.01
|
USD 30,036
|
|
|
2020-10-14 |
2020-10-14 |
B
Purchase
|
Hasnain Faheem
Non-Executive Director
|
96,520
+2.9%
10.36
USD 999,995
|
96,520
+2.9%
|
10.36
|
USD 999,995
|
|
|
2020-10-14 |
2020-10-14 |
B
Purchase
|
Christian Waage
EVP & General Counsel
Officer
|
2,500
+56.1%
9.53
USD 23,818
|
2,500
+56.1%
|
9.53
|
USD 23,818
|
|
|
2020-06-23 |
2020-06-23 |
B
Purchase
|
Giraudo Bryan
Chief Financial Officer
Officer
|
2,000
+94.3%
12.96
USD 25,922
|
2,000
+94.3%
|
12.96
|
USD 25,922
|
|
|
2019-12-31 |
2019-12-30 |
S
Sale
|
Dupont Jakob
Chief Medical Officer
Officer
|
40,000
-100.0%
15.00
USD 600,004
|
40,000
-100.0%
|
15.00
|
USD 600,004
|
|
|
2019-12-31 |
2019-12-27 |
S
Sale
|
Dupont Jakob
Chief Medical Officer
Officer
|
1,994
-100.0%
15.81
USD 31,534
|
1,994
-100.0%
|
15.81
|
USD 31,534
|
|
|
2019-09-27 |
2019-09-27 |
B
Purchase
|
Christian Waage
EVP & General Counsel
|
1,000
+29.0%
16.65
USD 16,654
|
1,000
+29.0%
|
16.65
|
USD 16,654
|
|
|
2019-09-27 |
2019-09-27 |
B
Purchase
|
Gujrathi Sheila
President & CEO
Executive Director
|
10,000
+0.2%
16.80
USD 167,980
|
10,000
+0.2%
|
16.80
|
USD 167,980
|
|
|
2019-09-27 |
2019-09-27 |
B
Purchase
|
Hasnain Faheem
|
10,000
+0.3%
16.80
USD 167,980
|
10,000
+0.3%
|
16.80
|
USD 167,980
|
|
|
2019-09-26 |
2019-09-26 |
B
Purchase
|
Giraudo Bryan
Chief Financial Officer
|
1,121
+112.1%
16.78
USD 18,810
|
1,121
+112.1%
|
16.78
|
USD 18,810
|
|
|
2019-09-23 |
2019-09-20 |
S
Sale
|
Omega Fund V, L.P.
Large shareholder
|
183,607
-2.7%
21.96
USD 4,032,561
|
183,607
-2.7%
|
21.96
|
USD 4,032,561
|
|
|
2019-09-18 |
2019-09-18 |
S
Sale
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
45,600
-0.7%
21.88
USD 997,637
|
45,600
-0.7%
|
21.88
|
USD 997,637
|
|
|
2019-09-18 |
2019-09-17 |
S
Sale
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
23,400
-0.3%
21.62
USD 505,791
|
23,400
-0.3%
|
21.62
|
USD 505,791
|
|
|
2019-09-18 |
2019-09-16 |
S
Sale
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
13,213
-0.2%
21.52
USD 284,331
|
13,213
-0.2%
|
21.52
|
USD 284,331
|
|
|
2019-09-12 |
2019-09-11 |
S
Sale
|
Omega Fund V, L.P.
Large shareholder
|
80,403
-1.2%
21.31
USD 1,713,629
|
80,403
-1.2%
|
21.31
|
USD 1,713,629
|
|
|
2019-09-12 |
2019-09-10 |
S
Sale
|
Omega Fund V, L.P.
Large shareholder
|
32,373
-0.5%
21.00
USD 679,865
|
32,373
-0.5%
|
21.00
|
USD 679,865
|
|
|
2019-09-09 |
2019-09-06 |
S
Sale
|
Omega Fund V, L.P.
Large shareholder
|
8,700
-0.1%
21.51
USD 187,103
|
8,700
-0.1%
|
21.51
|
USD 187,103
|
|
|
2019-09-09 |
2019-09-05 |
S
Sale
|
Omega Fund V, L.P.
Large shareholder
|
12,704
-0.2%
21.60
USD 274,434
|
12,704
-0.2%
|
21.60
|
USD 274,434
|
|
|
2019-08-29 |
2019-08-29 |
S
Sale
|
Salter-Cid Luisa
Chief Scientific Officer
Officer
|
26,252
-17.5%
20.09
USD 527,319
|
26,252
-17.5%
|
20.09
|
USD 527,319
|
|
|
2019-08-29 |
2019-08-28 |
S
Sale
|
Salter-Cid Luisa
Chief Scientific Officer
Officer
|
23,748
-13.6%
19.65
USD 466,724
|
23,748
-13.6%
|
19.65
|
USD 466,724
|
|
|
2019-06-03 |
2019-05-30 |
B
Purchase
|
Giraudo Bryan
Chief Financial Officer
|
1,000
+inf%
18.70
USD 18,700
|
1,000
+inf%
|
18.70
|
USD 18,700
|
|
|
2019-02-12 |
2019-02-12 |
B
Purchase
|
Christian Waage
EVP & General Counsel
Officer
|
1,550
+0.3%
16.00
USD 24,800
|
1,550
+0.3%
|
16.00
|
USD 24,800
|
|
|
2019-02-12 |
2019-02-12 |
B
Purchase
|
Cox Russell J.
Non-Executive Director
|
7,200
+inf%
16.00
USD 115,200
|
7,200
+inf%
|
16.00
|
USD 115,200
|
|
|
2019-02-12 |
2019-02-12 |
B
Purchase
|
Giraudo Bryan
Chief Financial Officer
Officer
|
6,000
+33.6%
16.00
USD 96,000
|
6,000
+33.6%
|
16.00
|
USD 96,000
|
|
